Pfizer and BioNTech are seeking give the immunization as two smaller, 10-microgram dose in this younger age group. For adults and children 12 years and older, the vaccine is given as two 30-microgram doses.
In the study, Pfizer and BioNTech tested this smaller dose on 2,268 children who were 5 to 11 years old. Their immune responses to the vaccine, measured by the level of virus-fighting antibodies in their blood, was similar to a group of 16- to 25-year-olds who received the standard 30-microgram dose.
The companies expect that the presence of these antibodies means the vaccine will help kids fend off the virus. But they didn't provide evidence that directly shows the vaccine is effective at preventing COVID-19 cases in this age group. The companies said side effects were comparable between 5-to-11 year olds and 16-to-25 year olds. The press release did not provide further specifics on the frequency and severity of side effects for this younger age group. The study results described in the release have not been published in a peer-reviewed medical journal.Sign up for notifications from Insider! Stay up to date with what you want to know.
Woohoo!
Get this done. POTUS, this should be your top priority right now. And while we’re at it, Mair it like MMR, etc. in terms of school admission. There’s no sound argument as to why we shouldn’t add it to the list.
😡
Disgusting
Likely to work - fire away!
Likely.
good
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »
Source: AP - 🏆 728. / 51 Read more »
Source: ABC - 🏆 471. / 51 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »
Covid-19: 'Vaccine misinformation a dilemma for young people'NI's mental health champion says it has left young people questioning if Covid jab is safe. Pretty sure plenty of accurate information has left them questioning.
Source: bbchealth - 🏆 143. / 63 Read more »